The first ever scientific study on microdosing psychedelics found very promising results. Comparing people who microdose with those who don’t found that microdosers had healthier scores on key mental health and well-being measures.
Those microdosing scored higher on measures of wisdom, open-mindedness and creativity and scored lower on measures of dysfunctional attitudes and negative emotionality.
No matter the substance, microdosing implies a dose so low that the individual experiences only subtle changes, not hallucinations. People are not “tripping” on a microdose.
Researchers state “No experimental study has evaluated psychedelic microdosing, and neither did we. Randomized placebo-controlled trials are needed to talk definitively about the effects of microdosing. In the meantime, we investigated the experiences of people who already microdose.”
The study also showed people report downsides to microdosing. Some people found microdosing increased anxiety and mood-instability; increased aches, pains and gastrointestinal distress were also common.